| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 59 | / | 2014 | ||||||||
| Date of issue: | 2014-06-05 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Sopharma monthly May 2014 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD (the “Company") notifies that for May 2014 the Company recorded a decrease of sales revenues of 14% compared to the same period of 2013, including same level of domestic sales and 18% decrease of export sales. The decline in export sales is mainly due to the stagnation of the Ukrainian market and the difficult access to the eastern regions of Ukraine. During the past five months Sopharma AD recorded a decrease of sales revenues of 2%, including 2% increase of domestic sales and 3% decrease of export sales compared to 2013. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Sopharma monthly May 2014.doc | Sopharma monthly May 2014 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2014-06-05 | Ognian Donev | Executive director | |||
